New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List ...Middle East

PR Newswire - News
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the new...

Hence then, the article about new indication of olverembatinib included into china 2024 national reimbursement drug list was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News